Emergent BioSolutions, Inc. (EBS)
6.23
+0.36
(+6.13%)
USD |
NYSE |
Sep 11, 16:00
6.25
+0.02
(+0.32%)
After-Hours: 20:00
Emergent BioSolutions Price : 6.23 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 5.98 | 6.39 | 5.875 | 6.23 | 1.299M |
| Sep 10, 2026 | 5.59 | 5.99 | 5.50 | 5.87 | 2.392M |
| Sep 09, 2026 | 5.96 | 6.04 | 5.605 | 5.68 | 1.174M |
| Sep 08, 2026 | 6.15 | 6.15 | 5.96 | 6.00 | 703242.0 |
| Sep 04, 2026 | 6.26 | 6.30 | 6.14 | 6.21 | 998575.0 |
| Sep 03, 2026 | 6.56 | 6.60 | 5.97 | 6.23 | 1.098M |
| Sep 02, 2026 | 6.23 | 6.50 | 6.23 | 6.46 | 1.034M |
| Sep 01, 2026 | 6.16 | 6.285 | 5.995 | 6.22 | 972440.0 |
| Aug 31, 2026 | 5.88 | 6.115 | 5.80 | 6.10 | 1.126M |
| Aug 28, 2026 | 5.96 | 6.11 | 5.88 | 5.91 | 1.244M |
| Aug 27, 2026 | 5.98 | 6.005 | 5.75 | 5.94 | 1.304M |
| Aug 26, 2026 | 5.56 | 6.00 | 5.55 | 5.97 | 1.166M |
| Aug 25, 2026 | 5.20 | 5.67 | 5.20 | 5.64 | 1.363M |
| Aug 24, 2026 | 5.02 | 5.22 | 5.00 | 5.18 | 871184.0 |
| Aug 21, 2026 | 4.79 | 5.105 | 4.75 | 5.08 | 1.419M |
| Aug 20, 2026 | 4.88 | 4.935 | 4.58 | 4.82 | 1.509M |
| Aug 19, 2026 | 4.81 | 4.92 | 4.735 | 4.89 | 1.593M |
| Aug 18, 2026 | 4.46 | 4.67 | 4.46 | 4.66 | 746279.0 |
| Aug 17, 2026 | 4.50 | 4.58 | 4.43 | 4.50 | 695643.0 |
| Aug 14, 2026 | 4.50 | 4.67 | 4.45 | 4.59 | 1.095M |
| Aug 13, 2026 | 4.52 | 4.73 | 4.45 | 4.49 | 1.461M |
| Aug 12, 2026 | 4.42 | 4.64 | 4.38 | 4.55 | 1.698M |
| Aug 11, 2026 | 4.47 | 4.53 | 4.370 | 4.45 | 1.755M |
| Aug 10, 2026 | 4.72 | 4.72 | 4.36 | 4.47 | 4.333M |
| Aug 07, 2026 | 5.40 | 5.55 | 4.81 | 4.84 | 3.141M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exelixis, Inc. | 56.12 |
| Capricor Therapeutics, Inc. | 8.37 |
| ADMA Biologics, Inc. | 9.23 |
| Akebia Therapeutics, Inc. | 0.9517 |
| Arcutis Biotherapeutics, Inc. | 23.88 |
Price Related Metrics
| PS Ratio | 0.4388 |
| Price to Book Value | 0.9361 |
| Price to Free Cash Flow | 3.934 |
| Earnings Yield | -57.04% |
| Market Cap | 319.60M |
| Operating PE Ratio | 2.469 |